Loading asset research
Grace Therapeutics Inc. Common Stock
GRCENasdaq · USD · StocksQuote as of · Exchange session not verified$2.22
-1.77%
Today
GRCE
Loading 1D prices…
Market cap
$46.7M
Volume
716K
52w high
$5.1852w low
$1.79Company profile
Grace Therapeutics Inc. Common Stock
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
PRINCETON, NJ, United States
Employees
5
Fiscal year end
0331
CIK
1444192
Session & valuation
Open$2.29
Previous close$2.26
Day high$2.46
Day low$2.20
30-day avg. volume174.5K
Outstanding shares21M
Diluted EPS-$0.47
Latest annual period
P/E (trailing)-4.72
P/E (forward)-4.79
Price / book0.75
Beta0.44
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CLNNClene Inc. Common Stock | $45.9M | $200K | -13086.50% | -$2.65 | -2.19% | Buy |
| ANVSAnnovis Bio Inc. Common Stock | $47.7M | $0.00 | — | -$1.40 | -5.88% | Buy |
| HOWLWerewolf Therapeutics Inc. Common Stock | $47.7M | $0.00 | — | -$1.33 | -0.82% | Buy |
| SCYXSCYNEXIS Inc. Common Stock | $48.2M | $20.6M | -41.79% | -$0.17 | +2.98% | Buy |
| MREOMereo BioPharma Group plc American Depositary Shares | $44.7M | $500K | +8375.60% | -$0.05 | +12.82% | Hold |